Lombard Medical, Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2015. For the quarter, the company's revenue was $4,227,000 compared with $4,268,000 a year ago. Operating loss was $9,380,000 compared with $8,715,000 a year ago. Loss before taxation was $9,683,000 compared with $8,679,000 a year ago. Loss for the period was $8,460,000 compared with $8,478,000 a year ago. Basic and diluted loss per ordinary share from continuing operations was 45.2 cents compared with 52.4 cents a year ago.

For the nine months, the company's revenue was $12,171,000 compared with $8,519,000 a year ago. Operating loss was $27,373,000 compared with $27,209,000 a year ago. Loss before taxation was $27,850,000 compared with $27,079,000 a year ago. Loss for the period was $26,199,000 compared with $26,469,000 a year ago. Basic and diluted loss per ordinary share from continuing operations was 153.8 cents compared with 189.0 cents a year ago. Net cash outflow from operating activities was $25,509,000 compared with $24,016,000 a year ago. Purchase of property, plant and equipment was $1,017,000 million compared with $1,519,000 a year ago. Purchase of intangible assets was $15,000 million compared with $245,000 million a year ago.

The company reaffirmed that it expects to achieve revenue for 2015 of between $15 million and $16 million.